Cite
HARVARD Citation
John, R. et al. (2019). Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems. Proceedings. 32 (2), pp. 187-191. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
John, R. et al. (2019). Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems. Proceedings. 32 (2), pp. 187-191. [Online].